...
首页> 外文期刊>Pharmaceutical Biology >Mechanism of Polysaccharides from Dendrobium huoshanense on Streptozotocin-Induced Diabetic Cataract
【24h】

Mechanism of Polysaccharides from Dendrobium huoshanense on Streptozotocin-Induced Diabetic Cataract

机译:霍山石end多糖对链脲佐菌素诱导的糖尿病白内障的作用机制

获取原文
获取原文并翻译 | 示例

摘要

The functional approach and molecular biological mechanism of polysaccharides from Dendrobium huoshanense C. Z. Tang et S. J. Cheng (Orchidaceae) on anticataract activity were assessed. Rats with intraperitoneal injection of streptozotocin (STZ; 45 mg kg~(-1)) were used as the animal model of diabetic cataract. Administration of polysaccharides from Dendrobium huoshanense (HPS) caused a significant body weight increase at dosages of 50, 100, and 200 mg kg"1 day"1, whereas blood sugar was decreased. Compared with rats without therapy, the opacity of lenses was abated in groups treated with HPS. Taking into account NO and NOS levels in lenses, 70.2 mu mol mg~(-1) protein of NO and 23.4 U mg~(-1) protein of NOS were obtained with a dosage of HPS at 200 mg kg~(-1)May~(-1), which all decreased more than 33% compared with those in the rats without therapy. RT-PCR analysis also showed that the inhibitory response of iNOS gene expression was in a dose-dependent manner with HPS treatment. To restrain advanced glycation end products (AGE) synthesis was another phenomenon in this experiment, and the suppression ratio reached 40.2% at 200 mg kg~(-1)day~(-1) treatment, compared with the rats without therapy. These results indicated that polysaccha-ride of D. huoshanense is a new pharmaceutical agent for prevention and cure of diabetic cataract.
机译:评估了霍山石poly多糖(兰科)的功能途径和分子生物学机制。腹腔注射链脲佐菌素(STZ; 45 mg kg〜(-1))作为糖尿病性白内障动物模型。施用霍山石end多糖(HPS)的多糖在50、100和200 mg / kg“ 1天” 1的剂量下引起体重的显着增加,而血糖却降低了。与未经治疗的大鼠相比,用HPS治疗的组的晶状体混浊度降低了。考虑到镜片中一氧化氮和一氧化氮的含量,以200 mg kg〜(-1)的HPS剂量可以得到70.2 mol mol〜(-1)的NO和23.4毫克〜(-1)的NOS。 May〜(-1),与未治疗的大鼠相比下降了33%以上。 RT-PCR分析还显示,HPS处理对iNOS基因表达的抑制作用呈剂量依赖性。抑制晚期糖基化终产物(AGE)的合成是该实验中的另一现象,与未治疗的大鼠相比,在200 mg kg〜(-1)day〜(-1)处理时抑制率达到40.2%。这些结果表明,霍山石poly多糖是预防和治疗糖尿病性白内障的新型药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号